B. Munos
Economics and Econometrics · 2006–2010
A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 13 researchers here, as inferred from the citation graph.
Subfields
- Economics and Econometrics — 5 citations into it; #5,922 of 23,481 by trust here, #3,046 by citations
Whom B. Munos trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Nassim Nicholas Taleb
- J. DiMasi
- Clayton M. Christensen
- Gary P. Pisano
- Arthur De Vany
- Henry G. Grabowski
Who trusts B. Munos overall
- Jackie Hunter
- Susie Stephens
- Knut Blind
- David W. Borhani
- David C. Swinney
- Fabio Pammolli
- I. Khanna
- Christine L. Ferguson
- Naomi Haefner
- Gisbert Schneider
Papers from B. Munos's perspective
Ordered by how strongly the researchers B. Munos trusts endorse each paper. Same corpus, a different order for every researcher.
- Seeing What's Next: Using the Theories of Innovation to Predict Industry Change
- Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
- The price of innovation: new estimates of drug development costs.
- The druggable genome (Nature reviews. Drug discovery)
- The Black Swan: The Impact of the Highly Improbable
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemia (Nature Genetics)
- PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008. (Journal of Lipid Research)
- The Pricing of Options and Corporate Liabilities
- Bricolage, Exemplars, Disunity and Performativity in Financial Economics
- The Innovator's Solution: Creating and Sustaining Successful Growth
Their papers
- Lessons from 60 years of pharmaceutical innovation (2009) — 1,147 citations
- How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010) — 3,532 citations
- Can open-source R&D reinvigorate drug research? (2006) — 123 citations